Lobbying

Alivecor's latest lobbying report covers Q4 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Veterans.

Alivecor

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Alivecor lobbying by quarter
Alivecor lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$30K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$01
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$205K · 11 reports
  • Veterans$175K · 8 reports
  • Labor, antitrust and workplace$65K · 5 reports
  • Trade$35K · 2 reports
  • Copyright, patent and trademark$30K · 3 reports
  • Telecommunications$10K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES11 reports
  • SENATE11 reports
  • Commerce, Dept of (DOC)6 reports
  • Health & Human Services, Dept of (HHS)4 reports
  • Treasury, Dept of4 reports
  • U.S. Trade Representative (USTR)4 reports
  • Patent & Trademark Office (PTO)2 reports
  • White House Office1 reports

Firms it paid

Firm
Forbes-Tate$520K13 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
01/17for Q4 2025Forbes-TateUnder $5,000
25/10/19for Q3 2025Forbes-Tate$50K
25/07/18for Q2 2025Forbes-Tate$50K
25/04/18for Q1 2025Forbes-Tate$50K
25/01/19for Q4 2024Forbes-Tate$50K
24/10/17for Q3 2024Forbes-Tate$50K
24/07/13for Q2 2024Forbes-Tate$50K
24/04/14for Q1 2024Forbes-Tate$50K
24/01/16for Q4 2023Forbes-Tate$50K
23/10/17for Q3 2023Forbes-Tate$20K
23/07/16for Q2 2023Forbes-Tate$20K
23/06/28for Q2 2023Forbes-TateUnder $5,000
23/04/24for Q1 2023Forbes-Tate$30K
23/04/17for Q1 2023Forbes-Tate$30K
23/01/15for Q4 2022Forbes-Tate$50K